chrisvoncsefalvay/vaers-outcomes huggingface dataset:
My father was in weak condition to begin with.  He didn't get out of bed for the next few days after receiving the vaccine.  The little amount that he ate was consumed in bed.  He began aspirating his food which lead to pneumonia.  He wasn't strong enough to fight off the pneumonia even with antibiotics.   He died on 1/23/21.   While he might have passed soon in any case, I believe that the vaccine may possibly have increased his weakness/exhaustion thereby hastening his demise.
Pt recvd MMR vax 2MAR87 & 25MAR87 pt devel lt sixth cranial nerve palsy; presented to MD 8APR87 & exam revealed lt esotropia of 40 & amblyopia of lt eye; CT scan neg; f/u info revealed pt had occlusion therapy for amblyopia in lt eye;
Pt recvd DTP #3 & HIB 26MAR92 & devel swelling of lt eye which appeared overnight;
chest pain; itch in the throat; chest pain radiating to the patient's back; This spontaneous report was received from a pharmacist and refers to a 75-year-old male patient. The patient's current condition included hypertension. The patient's concomitant medication included enalapril. The patient had none allergies or previous drug reactions.   On 29-DEC-2019, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # R022232, expiration date 16-APR-2020, intramuscular (dose and strength were not provided) to prevent pneumococcal disease. On 29-DEC-2019 (reported as later that same day), the patient experienced an itch in the throat. On an unknown date after that, the patient received unspecified antibiotics as a treatment. On 06-JAN-2020 (reported as 4 days ago), the patient experienced chest pain. On 09-JAN-2020, the pain began radiating to the patient's back. The patient sought medical attention and saw the pharmacist.  The outcome of the events was reported as not recovered. The causality assessment between the therapy and the events was not provided.
10/30 FLUZONE HD adm. Arm hurt at inj site but expected. about 11/6 while on cruise, putting on shirt and noticed having difficulty extending arm above head. 1/10/2014 Customers situation improved but still has difficulty extending arm upward.
Large red welt at injection site. Not itchy, but swollen, hot, and painful to the touch. Appeared about 24 hours after the injection.
Two weeks ago hospitalized with myopericarditis.  Was unaware that previous visits to urgent care for mild chest pain I thought was gas or bronchitis viral and bacterial issues were related. First antibiotics did not work and sometimes had to get a third but chest pain never went away and got worse.
4cm indurated area lt upper/outer arm w/redness extending approx 10cm; referred to MD for eval & recommended tx for ? cellulitis of area;
Chills; Achiness/soreness all over body; Low energy/very tired; Low energy/very tired; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 08Apr2021 at 14:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and high blood pressure. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 06:00, the patient experienced chills, achiness/soreness all over body and low energy/very tired. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, achiness/soreness all over body and low energy/very tired were resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
10/2021 Two months later after my 3rd vaccine, I went into A-fib and received an ablation for them to get my heart back into a sinus rhythm. I did have to go the ER in March or April due to my heart rate increasing so high. I don't know when my heart rate is elevating. December 27th, 2021, I started to wear a heart monitor due to increased issues. I increased my medication around January of 2022, and now I am getting this A-Fib and increased heart rate more frequently and for longer durations. April 26th 2022, 15%, 05/01/2022 heart rate elevation for 17% of the day. I went to a sleep clinic in August and received a C-Pap machine for sleep. Currently I am experiencing more increased heart rates, more frequently and for longer durations.
1/7/21 PM sore left arm at injection sight  1/10/21 PM severe congestion, headache, sinus pressure   1/11/21 AM severe headache, vertigo, shortness of breath, cough  1/11/21 AM went to get covid test due to being symptomatic,  tested positive.   I had a negative weekly (required by work) test done on 1/5/21 prior to getting vaccine.
This spontaneous report as received from a physician refers to unspecified number of patient of unknown age and gender. On unknown dates, the patient were vaccinated with doses of improperly stored GARDASIL 9 (lot # L013429, expiration date 21-JUL-2017, lot # L043213, expiration date 20-AUG-2017) (dose and route of administration not reported). The vaccines were exposed to the following conditions: temperature 1.5 degrees Centigrade for 1 hour. No adverse effect was reported. This is one of several reports from the same reporter. Additional information has been requested.
Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Bad headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HEADACHE (Bad headache). At the time of the report, HEADACHE (Bad headache) outcome was unknown.      No Concomitants and Treatment medications were reported.   Reporter did not allow further contact
Pain in left upper arm about 10 days after injection, shooting down arm to hand, reduced mobility of the arm, didn't improve for 3 weeks thus saw my own doctor. She referred to orthopaedic doctor. Saw him on 5/12/2021, he diagnosed adhesive capsulitis in left shoulder possibly caused or exacerbated by the swelling due to the vaccination in that same area. Revisit in 3 weeks after dr. visit. Taking ibuprofen to reduce inflammation.
over 42 days. 1st dose 06/13/21, 2nd dose 08/10/21
PATIENT RECEIVED 2 OF THE SAME INFLUENZA VACCINATIONS WITHIN A 3 MONTH PERIOD. NO ADVERSE EFFECTS EXPERIENCED.
pt has come down w/chicken pox-light case was exposed 2wk a/broke out;
By pm that night  my arm hurt to the point of not being able to touch it, it was also a little red and a bit warm.  I also noticed an electrical current in my body, tremorlike.  The redness and warmth went away the next morning, but my arm still aches incredibly bad.   I began to have palpatations at this point.  by 4pm I was very tired and achy.  this lasted the rest of the week, although the pain in my arm got a little better it is still uncomfortable.  On Thursday 03/ 25 my BP was 160s/100. That night the electrical current becam so intense and painful I had to keep moving.  Midnight I toox Mirapex , by this time my hands and feet were on fire.  felt like elctricity trying to escape. 3am ice/heat to sleep.
Large, itchy, red rash circling the injection site. The rash seems cutaneous only and it is raised as well.  Pregnancy History: 1 live birth in 2018; currently 4 weeks pregnant
it is hard to the touch; injection site became red (about 3" X 3" ); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (it is hard to the touch) and VACCINATION SITE ERYTHEMA (injection site became red (about 3" X 3" )) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE INDURATION (it is hard to the touch) and VACCINATION SITE ERYTHEMA (injection site became red (about 3" X 3" )). At the time of the report, VACCINATION SITE INDURATION (it is hard to the touch) and VACCINATION SITE ERYTHEMA (injection site became red (about 3" X 3" )) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
I developed deep muscle pain in my left hip and glute area. It progressed overnight to where I am now limping and bearing weight makes the joints slip making it difficult to walk.
Information has been received from a registered nurse concerning a 9 week old male with no pertinent medical history or drug allergies who on 20-NOV-2007 was vaccinated PO with a single dose of Rotateq (lot# 656659/0942U).  Concomitant vaccinations administered on that same day included a dose of PedvaxHIB (OMPC) (MSD), a dose of PEDIARIX and a dose of PREVNAR.  On 22-NOV-2007 the patient experienced vomiting and diarrhea.  On 23-NOV-2007 the patient was examined in the emergency room the day after symptoms started and was released that same day.  Laboratory diagnostic studies included unspecified tests.  The patient's stool also tested positive for rotavirus.  The patient also contacted the physician's office for medical attention.  Subsequently, the patient recovered. There was no product quality complaint.  It was also noted that on 24-NOV-2007 the patient's parents experienced gastrointestinal symptoms (unspecified) which lasted 48 hours then resolved (WAES# 0712USA04831).
Experienced hearing loss, & several days after that began to experience both imbalance-room spins when she turns to the lt, & ocean wave type sounds in her lt ear;
Pt vaccinated /w DTP/OPV fell asleep /p shot, woke up w/5cm reddened area over lt leg where shot given, had high pitched inconsolable crying. Finally did stop /p  1 1/2 hrs when baby fell asleep in care on way to clinic. Exam by Dr., pt OK
Seen by provider 12/10/2015 - ibuprofen ice/heat stretch. 12/17/2015 seen by another provider - declined imaging same area. 1/11/2016 0 physical - shoulder much better. 2/18/2016 secure message still having shoulder pain. 2/23/16 - Dr apt - referred to ortho.
Pt noted increasing swelling to maximum of 8 inches by 5 inches at site of injection. smaller area -- @inch dimater of redness w "bumps".
Headache, Myalgia, Arthralgia, Fever,  injection site pain/redness/swelling, chills, fatigue, night sweats Narrative:  Employee reports experiencing fever, chills, night sweats, headaches, joint and muscle aches, fatigue, and injection site pain/swelling/redness. Reports all symptoms have resolved.
LETHARGIC; CHILLS; FEVER; BONE ACHINESS; This spontaneous report received from a patient via a company representative concerned a 48 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patent had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1804025, and batch number: 1804025 expiry: UNKNOWN) .5 ml, administered on 10-MAR-2021 14:30 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced bone achiness. On 10-MAR-2021, the subject experienced chills. On 10-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced lethargic. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from bone achiness, and chills on 11-MAR-2021, was recovering from fever, and had not recovered from lethargic. This report was non-serious.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 59-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 at 16:00 as dose 5 (booster), single (Lot number: GH9703) at the age of 59 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (17Dec2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 07Dec2022 to 12Dec2022. Clinical Course: Country: Patient received other medication of atarvostatin in 2weeks as from 01Dec2022 to 07Dec2022. Patient became symptomatic and positive on 17Dec2022, it was unknown if patient recovered. Patient did not receive treatment.  The information on the batch/lot number for [BNT162B2, BNT162B2 OMI BA.4-5] has been requested and will be submitted if and when received.
Same day of injection patient developed redness in circular pattern around injection site. In addition patient reported fever and achiness last night. Resolved overnight but redness still remains
Child felt dizzy at time of vaccine. Mom and child walked to car. When they were a few blocks from our office mother called and stated child had vomited X1.
Severe swollen lymph node on the left side of the neck, clavicle area, and left armpit.  Constant headaches since the vaccination.   Injection site still swollen.   Anti inflammatory OTC.  Still swollen lymph nodes even five days later.
three days after the administration of Arexvy, their arm had gotten necrotic; This non-serious case was reported by a consumer via call center representative and described the occurrence of extremity necrosis in a female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   In OCT-2023, the patient received Arexvy. In OCT-2023, 3 days after receiving Arexvy, the patient experienced extremity necrosis (Verbatim: three days after the administration of Arexvy, their arm had gotten necrotic). The outcome of the extremity necrosis was unknown.   It was unknown if the reporter considered the extremity necrosis to be related to Arexvy.     It was unknown if the company considered the extremity necrosis to be related to Arexvy.   Additional Information: GSK receipt date: 13-NOV-2023 The patient called to inform that three days after the administration of Arexvy, their arm had gotten necrotic. According to the patient, the vaccine was received around the 3rd and 5th of October 2023, and the symptoms began 3 days after the administration of the vaccine. The patient also reported that the necrotic condition worsened after going to a cruise. Follow-up not possible as no contact details provided.
his arm is sore for a few days; Initial information was received on 19-Oct-2020 regarding an unsolicited valid non-serious case from a consumer or other nonprofessional.  This case involves a 65-year-old male patient who experienced his arm is sore for a few days (pain in extremity), while he received INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  Medical history, concomitant medication, past medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious his arm is sore for a few days (pain in extremity) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  It was reported that, the patient was 70 years old and ever since he turned 65, he has been getting the Fluzone High-Dose vaccine (lot number: UJ516AA,expiration date :30-Jun-2021) via intramuscular route in the left deltoid. He reports that he went to a drive through flu-shot clinic this year on 17-Oct-2020 and reports that every year, after he receives the vaccine, his arm is sore for a few days. This year, it doesn't/ didn't hurt at all.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  Outcome was unknown for the event at the time of reporting.  There will be no information available on the batch number for this case.
Within about 24 hours the soreness of my arm was different than any soreness with any previous vaccines.  We had been instructed at vaccination to avoid ibuprofen, etc for the first day or more after vaccine as could decrease? effectiveness of vaccine. As the week went on  my arm was becoming more sore particularly at night and stiffness in the morning.  I took ibuprofen at anti-inflammatory dosages but due to stomach upset switched to naproxen.   I saw my PCP on 2/12/21.  On exam and history she diagnosed me with adhesive capsulitis (frozen shoulder)  She gave me a sheet of physical therapy excercises to do at home.  I did the excercises.  As a physician I consulted with a PA in orthopedics and spoke with 2 PT's.  They all said that until frozen shoulder reaches middle to end of frozen phase that formal PT would not provide much over home excercises. The pain continued to worsen and was disrupting sleep.   I saw the PA in my docs office on 4/30 because I was getting decrease total sleep and very disrupted sleep.  So much so that I just started crying in her office.   She  prescribed meloxicam and cyclobenzaprine and ordered an MRI.  She indicated that if there was a shoulder injury that I had been unaware that PT vould be helpful and that if it was frozen shoulder PT not likely to be helpful.
Tinnitus. 5 days later ringing in the ears getting louder. There is no cure so I have not seen a doctor.
Pt received Pfizer x2.  Pt tested COVID + on 8/11/21 and admitted to hospital for COVID on 8/11/2021. Pt received remdesivir, tocilizumab and dexamethasone.
Vertigo and throwing up; Vertigo and throwing up; This is a spontaneous report from a contactable consumer reported for herself.   A 90-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), from lot number: EK9231 on 23Jan2021 (at the 90-year-old), at single dose for COVID-19 immunization via unspecified route of administration at the left arm. Medical history included vertigo seven years ago and she had taken a Meclizine for it. The patient wore hearing aids On the day of first COVID-19 Vaccine she was perfectly healthy. She was very alert for a 90-year-old. The patient had received influenza vaccine on unknown date. On 11Feb2021 the patient experienced Vertigo and throwing up. The patient was hospitalized for the events from 11Feb2021 to 13Feb2021. The patient received Meclizine, but it wasn't helping. The patient was admitted for 3 days until she felt well enough. The hospital took a blood test with unknown result. The patient did a little bit of physical therapy and she was given mostly IV fluids because she was throwing up. The outcome of the events was unknown.
rash on the  arm; felt really tired; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on the  arm) and FATIGUE (felt really tired) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced FATIGUE (felt really tired). On an unknown date, the patient experienced RASH (rash on the  arm). At the time of the report, RASH (rash on the  arm) and FATIGUE (felt really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history  and relevant concomitant medications weren't reported Treatment information was not provided
Non-dose-related adverse reaction to medication, initial encounter Diagnosis management comments: Patient is a 54-year-old female with a history of hyperlipidemia presenting to the ED with complaints of dizziness and headache after receiving the second dose of the COVID-19 vaccine.  Upon presentation to the ED and exam, patient reports that she is feeling a lot better at this time.  She denies any chest pain, shortness of breath, hives or any feelings of her throat closing.  On exam the patient's heart rate is regular lung sounds are clear.  No evidence of rash noted.  No angioedema noted on exam.  She was given p.o. Tylenol here in the emergency department.  She was monitored here in the emergency department with no further adverse reactions noted.
5/27 81y.o. farmer's wife who has a 6 month history of progressive SOB with exertion.
This initial non-serious spontaneous case, was received on 01-Nov-2017, from a physician, concerning an adult female patient of unspecified age. This refers 44 of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported).  It was reported that, the vaccine was stored in cooler with ice packs for 6 days and had reached unknown temperature during transport (explicitly considered as incorrect product storage) instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient (explicitly considered as drug administration error). The reporter stated that the temperature was not monitored on 24-Oct-2017 (could have been between 2-8C, but not certain) and there were no reports of adverse effect after vaccination (no adverse effect). The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly.
Left arm red, hot, swollen. Shot given 11/14/2001. Came to clinic 11/16/2001. MD recommended him to take Benadryl and cold compresses.